Found 6 matching trials
Efficacy and Immunogenicity Study of Recombinant Human Papillomavirus Bivalent(Type 16/18 )Vaccine
PHASE3This is a Phase III clinical trial of the novel recombinant HPV 16/18 bival...
Location
Cancer Institute & Hospital Chinese Academy of Medical Sciences
The Durability of Protection Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female
N/AThe primary objective of this study is to evaluate the durability of protec...
Location
Peking University People's Hospital
Dose-Ranging Study of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine
PHASE2This is a phase II clinical study of the novel recombinant HPV 16/18 bivale...
Location
Jiangsu Provincial Centre for Disease Control and Prevention
The Durability of Protection and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female
N/AThe primary objective of this study is to evaluate the durability of protec...
Location
Henan Cancer Hospital
A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV Vaccine
PHASE1This study is to evaluate the safety and tolerability profile of Recombinan...
Location
CDC, Jiangsu Province
A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV Vaccine
PHASE2This trail is to evaluate the safety profile of Recombinant Nonavalent (Typ...
Location
CDC, Jiangsu Province